NCT05922722 Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus Status COMPLETED Phase N/A
NCT05715463 Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity Status ACTIVE_NOT_RECRUITING Phase NA
NCT05612750 Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study Status RECRUITING Phase NA
NCT05321108 Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus Status UNKNOWN Phase NA
NCT05018858 Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus Status RECRUITING Phase PHASE1
NCT04806620 Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research Status RECRUITING Phase N/A
NCT04334031 Deployment o the Multidisciplinary Prospective Cohort Imminent Status RECRUITING Phase NA
NCT04065932 A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets Status COMPLETED Phase PHASE1
NCT04031469 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease Status SUSPENDED Phase N/A
NCT03953690 Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France Status TERMINATED Phase N/A
NCT03952624 Patient-Centered Assessment of Symptoms and Outcomes Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03402087 A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients Status COMPLETED Phase PHASE1
NCT03142412 Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization Status UNKNOWN Phase N/A
NCT02857452 Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire Status COMPLETED Phase N/A
NCT02265744 Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT01389895 Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus Status TERMINATED Phase PHASE1
NCT01172002 Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis Status UNKNOWN Phase NA